GANX compared with ZDGE: revenue, margins and what each company keeps, and the suppliers and customers both name

GANXGain Therapeutics, Inc.

Mkt capRevenueRevenue

ZDGEZedge, Inc.

Mkt capRevenueRevenue

Compare

GANXGain Therapeutics, Inc.

ZDGEZedge, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

GANX1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±8.5%▲+2.91%×0.34

ZDGE1 of 4 reports

Reportimpliedrealized× implied

Oct 27 '26—▼−7.25%—

= impliedGANX realized, solidZDGE realized, hatchedOne scale, both sides: full bar = 9%× = |realized| ÷ impliedSource: market data

GANXGain Therapeutics, Inc.

1.14· pre 1.15

Mkt cap$49.3MRevenue—Revenue—

ZDGEZedge, Inc.

2.35· pre 2.35· delayed

Pre-marketSep 2 '83

Mkt cap$30.4MRevenue$8MQ4 FY26Revenue$32MFY26

Compare

Pre-marketSep 2 '83

GANXGain Therapeutics, Inc.

ZDGEZedge, Inc.

1.14pre 1.15

Price

2.35pre 2.35delayed

$49.3M

Mkt cap

$30.4M

—

Revenue

$8MQ4 FY26

—

Revenue

$32MFY26

GANX1.14vsZDGE2.35Pre-marketSep 2 '83